| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3416105 | Microbes and Infection | 2007 | 7 Pages |
Abstract
Malaria vaccine development has so far been largely focused on antigens involved in parasite invasion pathways rather than on antigens associated with severe disease and naturally acquired immunity. Individuals repeatedly exposed to Plasmodium falciparum will eventually become immune to severe disease. Parasite-derived antigens expressed on the infected red blood cell (iRBC) surface are the main targets of protective immunity and can be explored as a rational alternative in development of an anti-malaria vaccine.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Qijun Chen,